NeoGenomics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
/ 
Frequently asked questions
To buy NeoGenomics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NeoGenomics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NeoGenomics Inc. is NEO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NeoGenomics Inc. has its primary listing on NASDAQ (Small cap). You can trade NeoGenomics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NeoGenomics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NeoGenomics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NeoGenomics Inc..